Skip to main content

Table 4 Predictors of LDL-C goal attainment

From: First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients

 

Initial model

Final model

 

OR (95% CIs)

P-value

OR (95% CIs)

P-value

Male gender

1.66 (0.88-3.13)

0.1

1.88 (1.03-3.44)

0.04

Age

1.02 (0.99-1.04)

0.3

  

DM

0.92 (0.49-1.76)

0.8

  

Smoking

0.62 (0.36-1.07)

0.09

0.57 (0.33-0.96)

0.04

CAD

1.34 (0.65-2.77)

0.4

  

PAD

1.53 (0.65-3.58)

0.3

  

Cerebrovascular disease

0.14 (0.02-1.004)

0.05

0.15 (0.02-1.14)

0.07

Baseline LDL-C (mg/dl)

0.99 (0.98-0.99)

<0.001

0.99 (0.98-0.99)

<0.001

Combined therapy with statin and ezetimibe

1.15 (0.56-2.34)

0.7

  

Very high potency LDL-C lowering regimen

1.94 (0.84-4.49)

0.1

2.21(1.15-4.24)

0.02

  1. DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.